An observational study in Overweight and Obesity, sponsored by Liverpool Hope University. Suspended at 1 site in United Kingdom. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-05-10.
Sponsored by Liverpool Hope University · Observational
Among 452 studies in Obesity with a site in United Kingdom — 92 open to participants now, 126 under way, 39 of them phase 3. Obesity · United Kingdom.
Among the 452 studies in Obesity with a site in United Kingdom, this one is the 31st largest by planned enrollment of the 81 observational ones that give a count, is one of 25 that started in 2019, is one of 81 observational ones, and was the 251st registered.
11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.
Browse Obesity studies →92 of the 452 studies in Obesity with a site in United Kingdom are open now. Recruiting first, the newest first:
Elenzia · Sites in United Kingdom
StudySetGo · Sites in United Kingdom
Ascletis Pharma (China) Co., Limited · Sites in United Kingdom, United States, Canada and 4 more countries
Ascletis Pharma (China) Co., Limited · Sites in United Kingdom, United States, Czechia and 3 more countries
AstraZeneca · Sites in United Kingdom, United States, Argentina and 8 more countries
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 1,336 Obesity studies recruiting now, 377 (28%) set no upper age limit and 856 (64%) stop at 75 or younger; 168 take children under 18; 491 take healthy volunteers.
This study: 18 Years to 50 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
452 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 31 · Phase 2 36 · Phase 3 75 · Phase 4 12
First in 2001; this study’s year is marked. 25 started in 2019.
This study's planned enrollment of 300 is above the median of 114 across 2,154 observational studies indexed under Obesity.
Median enrollment 65 across the 370 interventional studies, 130 across the 81 observational. Of the 272 that completed or were terminated, 52 (19%) have results posted.
This tab as a report to print or save as PDF → With an account.
139 of 452 have an industry lead sponsor. The 10 most frequent:
Liverpool Hope University is the lead sponsor of 6 studies on the registry; 1 is open to participants now.
Liverpool Hope University has 2 studies filed under Obesity — fewer than ten, so there is no comparison to draw.
29 of the studies in Obesity with a site in United Kingdom that are under way reach primary completion within a year, 10 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06858839Phase 3AmgenEvaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight | 2027-01-21 |
| NCT06858878Phase 3AmgenEfficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight | 2027-01-21 |
| NCT06672549Phase 3Eli Lilly and CompanyA Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) | 2027-02 |
| NCT07220642Phase 3Novo Nordisk A/SWeight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide | 2027-05-11 |
| NCT07220759Phase 3Novo Nordisk A/SWeight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide | 2027-05-12 |
Among the 452 studies in Obesity with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is exploring the association between vitamin D and Type 2 diabetes risk in normal weight and overweight UK adults.
The aim of this study is to assess the link between vitamin D status and glucose homeostasis in a population of normal weight and overweight individuals (BMI> 18.5 Kg/m2).
11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.
This study's planned enrollment of 300 is above the median of 114 across 2,154 observational studies indexed under Obesity.
Browse Obesity studies →Liverpool Hope University is the lead sponsor of 6 studies on the registry; 1 is open to participants now.
Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Overweight. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Overweight and obese adults , aged 18-50 (premenopausal women), males and females with no known chronic conditions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Postmenopausal
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Association between vitamin D levels and insulin resistance
HOMA-IR (Homeostasis modelling assessment-Insulin resistance)
A venous blood sample collected for the measurement of insulin and glucose levels.
Time frame: One venous sample collected after 8 hours of fasting
Fasting bood glucose levels
A venous blood sample collected for the measurement of glucose levels
Time frame: One venous sample collected after 8 hours of fasting
HbA1C
Fingerprick sample
Time frame: Sample collected at one single time point with no follow-up
Body fat percentage
Body fat percentage measured through DEXA
Time frame: Measurement conducted in the morning after 8 hours of fasting
Central and brachial Systolic and Diastolic Blood pressure
Blood pressure measured using a digital sphygmomanometer
Time frame: Measurement taken 3 times after a-10 minute rest
Augmentation index
Arterial stiffness assessment test
Time frame: Measurement taken 3 times after a-10 minute rest
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2019 (actual). Primary completion is estimated for Jul 2022, 36 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is suspended, as verified in May 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Liverpool Hope University